Sociodemographic, socioeconomic, and clinical determinants of survival in patients with cancer: A systematic review of the literature focused on the elderly

2018 ◽  
Vol 9 (1) ◽  
pp. 6-14 ◽  
Author(s):  
Angéline Galvin ◽  
Fleur Delva ◽  
Catherine Helmer ◽  
Muriel Rainfray ◽  
Carine Bellera ◽  
...  
CoDAS ◽  
2015 ◽  
Vol 27 (4) ◽  
pp. 400-406 ◽  
Author(s):  
Valquíria Conceição Souza ◽  
Stela Maris Aguiar Lemos

PURPOSE: To systematically review studies that used questionnaires for the evaluation of restriction on auditory participation in adults and the elderly.RESEARCH STRATEGY: Studies from the last five years were selected through a bibliographic collection of data in national and international journals in the following electronic databases: ISI Web of Science and Virtual Health Library - BIREME, which includes the LILACS and MEDLINE databases.SELECTION CRITERIA: Studies available fully; published in Portuguese, English, or Spanish; whose participants were adults and/or the elderly and that used questionnaires for the evaluation of restriction on auditory participation.DATA ANALYSIS: Initially, the studies were selected based on the reading of titles and abstracts. Then, the articles were fully and the information was included in the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist.RESULTS: Three-hundred seventy studies were found in the researched databases; 14 of these studies were excluded because they were found in more than one database. The titles and abstracts of 356 articles were analyzed; 40 of them were selected for full reading, of which 26 articles were finally selected. In the present review, nine instruments were found for the evaluation of restriction on auditory participation.CONCLUSION: The most used questionnaires for the assessment of the restriction on auditory participation were the Hearing Handicap Inventory for the Elderly (HHIE), Hearing Handicap Inventory for Adults (HHIA), and Hearing Handicap Inventory for the Elderly - Screening (HHIE-S). The use of restriction on auditory participation questionnaires can assist in validating decisions in audiology practices and be useful in the fitting of hearing aids and results of aural rehabilitation.


2013 ◽  
Vol 69 (3) ◽  
pp. e121-e128 ◽  
Author(s):  
Kira Minkis ◽  
Benjamin C. Garden ◽  
Shenhong Wu ◽  
Melissa P. Pulitzer ◽  
Mario E. Lacouture

2015 ◽  
Vol 14 (1) ◽  
pp. 77-84 ◽  
Author(s):  
Fernando Espi Forcen ◽  
Konstantina Matsoukas ◽  
Yesne Alici

AbstractObjective:Akathisia is a neuropsychiatric syndrome characterized by subjective and objective restlessness. It is a common side effect in patients taking antipsychotics and other psychotropics. Patients with delirium are frequently treated with antipsychotic medications that are well known to induce akathisia as a side effect. However, the prevalence, phenomenology, and management of akathisia in patients with delirium remain largely unknown. The purpose of this review was to examine the medical literature in order to establish the current state of knowledge regarding the prevalence of antipsychotic-induced akathisia in patients with delirium.Method:A systematic review of the literature was conducted using the EMBASE, MEDLINE, PsycINFO, and CINAHL databases. Ten studies addressing the incidence of akathisia in patients taking antipsychotic medication for delirium were identified and included in our review.Results:The included studies reported a variable prevalence of antipsychotic-induced akathisia. A higher prevalence was found in patients taking haloperidol. Among atypical antipsychotics, paliperidone and ziprasidone were associated with a higher risk of akathisia. The risk for akathisia appeared to be a dose-related phenomenon.Significance of results:Studies using specific scales for evaluation of akathisia in delirium are lacking. Some populations, such as patients with cancer or terminally ill patients in palliative care settings taking antipsychotics for the treatment of delirium, could be at higher risk for development of akathisia as a side effect.


2021 ◽  
Vol 12 ◽  
pp. 624
Author(s):  
Joseph Merola ◽  
Susruta Manivannan ◽  
Setthasorn Ooi ◽  
Wen Li Chia ◽  
Milan Makwana ◽  
...  

Background: Intracranial arachnoid cysts (AC) are benign, cerebrospinal fluid filled spaces within the arachnoid layer of the meninges. Neurosurgical intervention in children and young adults has been extensively studied, but the optimal strategy in the elderly remains unclear. Therefore, we performed a single center retrospective study combined with a systematic review of the literature to compare cystoperitoneal (CP) shunting with other surgical approaches in the elderly cohort. Methods: Retrospective neurosurgical database search between January 2005 and December 2018, and systematic review of the literature using PRISMA guidelines were performed. Inclusion criteria: Age 60 years or older, radiological diagnosis of intracranial AC, neurosurgical intervention, and neuroradiological (NOG score)/clinical outcome (COG score). Data from both sources were pooled and statistically analyzed. Results: Our literature search yielded 12 studies (34 patients), which were pooled with our institutional data (13 patients). CP shunts (7 patients; 15%), cyst fenestration (28 patients; 60%) and cyst marsupialisation/resection (10 patients; 21%) were the commonest approaches. Average duration of follow-up was 23.6, 26.9, and 9.5 months for each approach, respectively. There was no statistically significant association between choice of surgical intervention and NOG score (P = 0.417), COG score (P = 0.601), or complication rate (P = 0.955). However, CP shunting had the lowest complication rate, with only one patient developing chronic subdural haematoma. Conclusion: CP shunting is a safe and effective surgical treatment strategy for ACs in the elderly. It has similar clinical and radiological outcomes but superior risk profile when compared with other approaches. We advocate CP shunting as first line neurosurgical intervention for the management of intracranial ACs in the elderly.


2012 ◽  
Vol 47 (4) ◽  
pp. 281-289 ◽  
Author(s):  
Simone Scarlata ◽  
Luisa Costanzo ◽  
Renato Giua ◽  
Claudio Pedone ◽  
Raffaele Antonelli Incalzi

2005 ◽  
Vol 1 ◽  
pp. S62-S62 ◽  
Author(s):  
Kay Noel ◽  
James Hoffman ◽  
Lorie Ellis ◽  
Karin Yurko-Mauro ◽  
Catherine Cella ◽  
...  

2007 ◽  
Vol 97 (5) ◽  
pp. 823-831 ◽  
Author(s):  
Ramón Colomer ◽  
José M. Moreno-Nogueira ◽  
Pedro P. García-Luna ◽  
Pilar García-Peris ◽  
Abelardo García-de-Lorenzo ◽  
...  

Use of n-3 fatty acids (FA) has been reported to be beneficial for cancer patients. We performed a systematic review of the literature in order to issue recommendations on the clinical use of n-3 FA in the cancer setting. A systematic search was performed in MEDLINE, EMBASE, Cochrane and Healthstar databases. We selected clinical trials or prospective observational studies including patients with cancer and life expectancy >2 months, in which enteral supplements with n-3 FA were administered. Parameters evaluated individually were clinical (nutritional status, tolerance, survival and hospital stays), biochemical (inflammatory mediators), and functional (functional status, appetite and quality of life (QoL)). Seventeen studies met the inclusion criteria; eight were of high quality. The panel of experts established the following evidence: (1) oral supplements with n-3 FA benefit patients with advanced cancer and weight loss, and are indicated in tumours of the upper digestive tract and pancreas; (2) the advantages observed were: increased weight and appetite, improved QoL, and reduced post-surgical morbidity; (3) there is no defined pattern for combining different n-3 FA, and it is recommended to administer >1·5 g/day; and (4) better tolerance is obtained administering low-fat formulas for a period of at least 8 weeks. All the evidences were grade B but for ‘length of treatment’ and ‘advantage of survival’ it was grade C. Our findings suggest that administration of n-3 FA (EPA and DHA) in doses of at least 1·5 g/day for a prolonged period of time to patients with advanced cancer is associated with an improvement in clinical, biological and QoL parameters.


Sign in / Sign up

Export Citation Format

Share Document